Novel analogues of degarelix incorporating hydroxy-, methoxy-, and pegylated-urea moieties at positions 3, 5, 6 and the N-terminus. Part III.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2006-06-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM060240APMID 16759096PMCID PMC2536684
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New method for the synthesis of N-methyl amino acids containing peptides by reductive methylation of amino groups on the solid phase.

  2009cited by this paper
• A new general solid-phase method for the synthesis of backbone-to-backbone cyclized peptides.

  2009cited by this paper
• Iterative approach to the discovery of novel degarelix analogues: substitutions at positions 3, 7, and 8. Part II.

  2005cited by this paper
• Novel gonadotropin‐releasing hormone antagonists with substitutions at position 5

  2005cited by this paper
• Discovery of a thieno[2,3-d]pyrimidine-2,4-dione bearing a p-methoxyureidophenyl moiety at the 6-position: a highly potent and orally bioavailable non-peptide antagonist for the human luteinizing hormone-releasing hormone receptor.

  2003cited by this paper
• Effective drug delivery by PEGylated drug conjugates.

  2003cited by this paper
• A general method for the solid-phase synthesis of unsymmetrical tri- and tetrasubstituted ureas.

  2002cited by this paper
• Solid-phase synthesis of substituted imidazoline-tethered 2,3-diketopiperazines, cyclic ureas, and cyclic thioureas.

  2001cited by this paper
• GnRH antagonists: a new generation of long acting analogues incorporating p-ureido-phenylalanines at positions 5 and 6.

  2001cited by this paper
• Approaches to Alkaline Earth Metal-Organic Chemical Vapor Deposition Precursors. Synthesis and Characterization of Barium Fluoro-beta-ketoiminate Complexes Having Appended Polyether "Lariats"

  1998cited by this paper
• Future trends in infertility treatment: challenges ahead.

  1997cited by this paper
• Solid Phase Syntheses of Oligoureas

  1997cited by this paper
• Solid phase synthesis of ureas of secondary amines via carbamoyl chloride

  1997cited by this paper
• Peptide chemistry: development of high performance liquid chromatography and capillary zone electrophoresis.

  1996cited by this paper
• The Solid - Phase Synthesis of Oligoureas

  1996cited by this paper
• Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo.

  1995cited by this paper
• A strategy for urea linked diamine libraries

  1995cited by this paper
• Gonadotropin-releasing hormone antagonists: novel members of the azaline B family.

  1995cited by this paper
• Gonadotropin-releasing hormone causes transcriptional stimulation followed by desensitization of the glycoprotein hormone alpha promoter in transfected alpha T3 gonadotrope cells.

  1994cited by this paper
• Coupling N-methylated amino acids using PyBroP and PyCloP halogenophosphonium salts : mechanism and fields of application

  1994cited by this paper
• Peptoid mimics of a C2-symmetric inhibitor of the HIV-1 protease.

  1994cited by this paper
• The effect of NMeTyr5 substitution in luteinizing hormone-releasing hormone antagonists.

  1993cited by this paper
• Gonadotropin-releasing hormone antagonists with N omega-triazolylornithine, -lysine, or -p-aminophenylalanine residues at positions 5 and 6.

  1992cited by this paper
• The Preparation of Nα-t-Boc-2,3-Diaminopropionic Acid (DPR) and of Nα-t-Boc-2,4-Diaminobutyric Acid (DBR) Derivatives Suitable for Solid Phase Peptide Synthesis.

  1991cited by this paper
• Novel gonadotropin-releasing hormone antagonists: peptides incorporating modified N omega-cyanoguanidino moieties.

  1991cited by this paper
• Design, synthesis and bioassays of antagonists of LHRH which have high antiovulatory activity and release negligible histamine.

  1987cited by this paper
• In Vitro Histamine Release with LHRH Analogs

  1987cited by this paper
• New effective gonadotropin releasing hormone antagonists with minimal potency for histamine release in vitro.

  1986cited by this paper
• LHRH and its analogs : contraceptive and therapeutic applications

  1984cited by this paper
• [Ac-D-NAL(2)1,4FD-Phe2,D-Trp3,D-Arg6]-LHRH, a potent antagonist of LHRH, produces transient edema and behavioral changes in rats.

  1984cited by this paper
• Solid-phase peptide synthesis.

  1977cited by this paper
• LUTEINIZING HORMONE-RELEASING HORMONE. ANTIOVULATORY ACTIVITY OF ANALOGS SUBSTITUTED IN POSITIONS 2 AND 6

  1976cited by this paper
• Inhibition of the pre-ovulatory proestrous gonadotropin surge, ovulation and pregnancy with a peptide analogue of luteinizing hormone releasing hormone

  1975cited by this paper
• Ihibition of the pre-ovulatory proestrous gonadotropin surge, ovulation and pregnancy with a peptide analogue of luteinizing hormone releasing hormone.

  1975cited by this paper
• Luteinizing hormone-releasing hormone. Antiovulatory activity of analogs substituted in positions 2 and 6.

  1975cited by this paper
• Synthetic luteinizing hormone-releasing factor analogs. Series of short-chain amide LRF homologs converging to the amino terminus.

  1973cited by this paper
• Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence.

  1971cited by this paper
• Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides.

  1970cited by this paper
• Substituted diphenylmethyl protecting groups in peptide synthesis.

  1965cited by this paper
• Journal of the Chemical Society

  1875cited by this paper

• Multicomponent Approach to Libraries of Substituted Dihydroorotic Acid Amides.

  2019cites this paper
• Antineoplastic and Immunomodulating Agents (L)

  2017cites this paper
• Synthesis, Anticancer Evaluation and Docking Study of 3- Benzyloxyhydantoin Derivatives.

  2016cites this paper
• Gonadotropin‐releasing hormone receptor‐targeted paclitaxel–degarelix conjugate: synthesis and in vitro evaluation

  2015cites this paper
• Self‐assembled nanostructures of long‐acting GnRH analogs modified at position 7

  2014cites this paper
• Synthesis and anticancer evaluation of benzyloxyurea derivatives.

  2014cites this paper
• Rationally designed cyclic analogues of luteinizing hormone-releasing hormone: enhanced enzymatic stability and biological properties.

  2012cites this paper
• Update 1 of: α,β-Diamino acids: biological significance and synthetic approaches.

  2011cites this paper
• Structure-activity studies of urea, carbamate, and sulfonamide derivatives of acylfulvene.

  2010cites this paper
• Antineoplastic Agents, 2. Hormonally Acting

  2010cites this paper
• Luteinizing Hormone-Releasing Hormone and Its Agonistic, Antagonistic, and Targeted Cytotoxic Analogs in Prostate Cancer

  2010cites this paper
• Ureido-modification of the resin-bound LHRH analogue with N,N′-carbonyldiimidazole

  2009cites this paper
• Peptides as Therapeutic Agents or Drug Leads for Autoimmune, Hormone Dependent and Cardiovascular Diseases

  2008cites this paper
• Effective Mast Cell Degranulating Peptide Inhibitors of the IgE/FcɛRI Receptor Interaction

  2008cites this paper
• Amyloid as a Depot for the Formulation of Long-Acting Drugs

  2008cites this paper
• Structure-activity relationship studies of gonadotropin-releasing hormone antagonists containing S-aryl/alkyl norcysteines and their oxidized derivatives.

  2007cites this paper
• The effect of the [18F]-PEG group on tracer qualification of [4-(phenylamino)-quinazoline-6-YL]-amide moiety--an EGFR putative irreversible inhibitor.

  2007cites this paper
• Drug evaluation: Degarelix--a potential new therapy for prostate cancer.

  2006cites this paper
• Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR.

  2003cites this paper